These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24815863)

  • 1. Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma.
    Kaseb AO; Xiao L; Hassan MM; Chae YK; Lee JS; Vauthey JN; Krishnan S; Cheung S; Hassabo HM; Aloia T; Conrad C; Curley SA; Vierling JM; Jalal P; Raghav K; Wallace M; Rashid A; Abbruzzese JL; Wolff RA; Morris JS
    J Natl Cancer Inst; 2014 May; 106(5):. PubMed ID: 24815863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of an IGF-CTP scoring system for assessing hepatic reserve in Egyptian patients with hepatocellular carcinoma.
    Abdel-Wahab R; Shehata S; Hassan MM; Xiao L; Lee JS; Cheung S; Essa HH; Hassabo HM; Shalaby AS; Mosad E; Raghav K; Rashid A; Wolff RA; Morris JS; Amin HM; Kaseb AO
    Oncotarget; 2015 Aug; 6(25):21193-207. PubMed ID: 26098859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort.
    Huber Y; Bierling F; Labenz C; Koch S; Schmidtmann I; Kloeckner R; Schotten S; Huber T; Lang H; Woerns MA; Galle PR; Weinmann A; Weinmann-Menke J
    BMC Cancer; 2018 Jul; 18(1):774. PubMed ID: 30064393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area.
    Lee DH; Lee JH; Jung YJ; Gim J; Kim W; Kim BG; Lee KL; Cho Y; Yoo JJ; Lee M; Cho YY; Cho EJ; Yu SJ; Kim YJ; Yoon JH
    PLoS One; 2017; 12(1):e0170394. PubMed ID: 28107416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients.
    Abdel-Wahab R; Hassan MM; George B; Carmagnani Pestana R; Xiao L; Lacin S; Yalcin S; Shalaby AS; Al-Shamsi HO; Raghav K; Wolff RA; Yao JC; Girard L; Haque A; Duda DG; Dima S; Popescu I; Elghazaly HA; Vauthey JN; Aloia TA; Tzeng CW; Chun YS; Rashid A; Morris JS; Amin HM; Kaseb AO
    Oncology; 2020; 98(12):836-846. PubMed ID: 33027788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib.
    Mohamed YI; Lee S; Xiao L; Hassan MM; Qayyum A; Hiatia R; Pestana RC; Haque A; George B; Rashid A; Duda DG; Elghazaly H; Wolff RA; Morris JS; Yao J; Amin HM; Kaseb AO
    Oncotarget; 2021 Apr; 12(8):756-766. PubMed ID: 33889299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study.
    Lacin S; Yalcin S; Karakas Y; Hassan MM; Amin H; Mohamed YI; Rashid A; Morris JS; Xiao L; Qayyum A; Kaseb AO
    J Hepatocell Carcinoma; 2020; 7():143-153. PubMed ID: 32984091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score.
    Kaseb AO; Abbruzzese JL; Vauthey JN; Aloia TA; Abdalla EK; Hassan MM; Lin E; Xiao L; El-Deeb AS; Rashid A; Morris JS
    Oncology; 2011; 80(5-6):373-81. PubMed ID: 21822028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.
    Kaseb AO; Morris JS; Hassan MM; Siddiqui AM; Lin E; Xiao L; Abdalla EK; Vauthey JN; Aloia TA; Krishnan S; Abbruzzese JL
    J Clin Oncol; 2011 Oct; 29(29):3892-9. PubMed ID: 21911725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of insulin-like growth factor 1-Child-Turcotte-Pugh score for mortality in patients with decompensated cirrhosis.
    Yao Y; Yang D; Huang Y; Dong M
    Clin Chim Acta; 2020 Jun; 505():141-147. PubMed ID: 32119835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma.
    Kaseb AO; Guan Y; Gok Yavuz B; Abbas AR; Lu S; Hasanov E; Toh HC; Verret W; Wang Y
    J Hepatocell Carcinoma; 2022; 9():1065-1079. PubMed ID: 36254201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy.
    Su TS; Yang HM; Zhou Y; Huang Y; Liang P; Cheng T; Chen L; Li LQ; Liang SX
    Radiat Oncol; 2019 Mar; 14(1):50. PubMed ID: 30917853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram and Artificial Neural Network for Prognostic Performance on the Albumin-Bilirubin Grade for Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
    Zhong BY; Ni CF; Ji JS; Yin GW; Chen L; Zhu HD; Guo JH; He SC; Deng G; Zhang Q; Li PC; Yu H; Song JJ; Teng GJ
    J Vasc Interv Radiol; 2019 Mar; 30(3):330-338. PubMed ID: 30819473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database.
    Kaplan DE; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Knott A; Pedrosa M; Pocha C; Mehta R; Duggal M; Skanderson M; Valderrama A; Taddei TH;
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2333-41.e1-6. PubMed ID: 26188137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
    Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
    World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum insulin-like growth factor-I level is an independent predictor of recurrence and survival in early hepatocellular carcinoma: a prospective cohort study.
    Cho EJ; Lee JH; Yoo JJ; Choi WM; Lee MJ; Cho Y; Lee DH; Lee YB; Kwon JH; Yu SJ; Lee JM; Suh KS; Kim K; Kim YJ; Yoon JH; Kim CY; Lee HS
    Clin Cancer Res; 2013 Aug; 19(15):4218-27. PubMed ID: 23757355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma.
    Abou-Alfa GK; Capanu M; O'Reilly EM; Ma J; Chou JF; Gansukh B; Shia J; Kalin M; Katz S; Abad L; Reidy-Lagunes DL; Kelsen DP; Chen HX; Saltz LB
    J Hepatol; 2014 Feb; 60(2):319-24. PubMed ID: 24045151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new Child-Turcotte-Pugh class 0 for patients with hepatocellular carcinoma: determinants, prognostic impact and ability to improve the current staging systems.
    Lee YH; Hsu CY; Chu CW; Liu PH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
    PLoS One; 2014; 9(6):e99115. PubMed ID: 24906132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Noninvasive Fibrosis Markers and Postoperative Mortality After Hepatectomy for Hepatocellular Carcinoma.
    Maegawa FB; Shehorn L; Aziz H; Kettelle J; Jie T; Riall TS
    JAMA Netw Open; 2019 Jan; 2(1):e187142. PubMed ID: 30657533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Serum Insulin-Like Growth Factor 1 Level as a Prognostic Factor in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.
    Shen L; Xu L; Zhang J; Jiang D
    J Interferon Cytokine Res; 2018 Apr; 38(4):153-160. PubMed ID: 29638204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.